BULGHERONI, ELISABETTA
BULGHERONI, ELISABETTA
Universita' degli Studi di MILANO
Identification of Lymphangioleiomyomatosis-associated Serum MicroRNAs
2024 R.L. Rossi, D. Elia, O. Torre, R. Cassandro, A. Caminati, E. Bulgheroni, E. Carelli, C. Vasco, S. Abrignani, J. Geginat, S. Harari
Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells
2016 S. Harari, D. Elia, O. Torre, E. Bulgheroni, E. Provasi, J. Moss
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility : evidence of a selective haploinsufficiency gene effect
2013 M. Sala, D. Braida, A. Donzelli, R. Martucci, M. Busnelli, E. Bulgheroni, T. Rubino, D. Parolaro, K. Nishimori, B. Chini
Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation
2013 P. De Candia, A. Torri, T. Gorletta, M. Fedeli, E. Bulgheroni, C. Cheroni, F. Marabita, M. Crosti, M. Moro, E. Pariani, L. Romanò, S. Esposito, F. Mosca, G. Rossetti, R.L. Rossi, J. Geginat, G. Casorati, P. Dellabona, M. Pagani, S. Abrignani
Analysis of protease inhibitor combinations in vitro : activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates
2004 E. Bulgheroni, P. Citterio, F. Croce, M. Lo Cicero, O. Viganò, F. Soster, T.C. Chou, M. Galli, S. Rusconi
Entry and fusion inhibitors of HIV
2004 S. Rusconi, E. Bulgheroni, P. Citterio
Unusual codon 69 insertions : influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility
2004 E. Bulgheroni, F. Croce, P. Citterio, O. Viganò, R. Visonà, E. Sala, M. Galli, S. Rusconi
Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects
2002 S. Rusconi, E. Bulgheroni, S. La Seta-Catamancio, F.G. Croce, M. Lo Cicero, P.M. Citterio, M. Galli
Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine
2001 S. Rusconi, S. LA SETA CATAMANCIO, P. Citterio, E. Bulgheroni, S. Kurtagic, M. Galazzi, F.G. Croce, M. Moroni, M. Galli
In vitro inhibition of HIV-1 by Met-SDF-1beta alone or in combination with antiretroviral drugs
2000 S. Rusconi, D.P. Merrill, S. La Seta Catamancio, P. Citterio, E. Bulgheroni, F. Croce, T.C. Chou, O.O. Yang, S.H. Herrmann, M. Galli, M.S. Hirsch
In vitro inhibition of HIV-1 by Met-SDF-1β alone or in combination with antiretroviral drugs
2000 S. Rusconi, D.P. Merrill, S. La Seta Catamancio, P. Citterio, E. Bulgheroni, F. Croce, T.-. Chou, O.O. Yang, S.H. Herrmann, M. Galli, M.S. Hirsch
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection : in vitro studies of mixed virus infections
2000 S. Rusconi, S. La Seta Catamancio, P. Citterio, E. Bulgheroni, F. Croce, S.H. Herrmann, RE.O fford, M. Galli, M.S. Hirsch
Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure
1998 S. Rusconi, M. De Pasquale, L. Milazzo, S. Kurtagic, E. Bulgheroni, P.M. Citterio, M. Galazzi, S. La Seta-Catamancio, M. Galli
In vitro effects of continuous pressure with zidovudine (ZDV) and lamivudine on a ZDV-resistant HIV-1 isolate
1997 S. Rusconi, M. DePasquale, L. Milazzo, E. Bulgheroni, P.M. Citterio, S. Kurtagic, A. d' Arminio Monforte, M. Galli